Skip to main content
Graph Theory in Bioinformatics - From Data to Discovery

Graph Theory in Bioinformatics - From Data to Discovery

$296.00
When you get access:
Course access is prepared after purchase and delivered via email
How you learn:
Self-paced • Lifetime updates
Your guarantee:
30-day money-back guarantee — no questions asked
Toolkit Included:
Includes a practical, ready-to-use toolkit containing implementation templates, worksheets, checklists, and decision-support materials used to accelerate real-world application and reduce setup time.
Who trusts this:
Trusted by professionals in 160+ countries
Adding to cart… The item has been added

What does the Graph Theory in Bioinformatics - From Data to Discovery course cover?

Graph Theory in Bioinformatics - From Data to Discovery is covered here in 9 modules: Foundations of Graph Representation in Biological Systems, Construction of Multi-Omics Biological Networks, Topological Analysis of Biological Networks and 6 more. The outline lists 72 specific topics, opening with select appropriate graph types (directed, undirected, weighted, bipartite) for modeling protein-protein interaction networks based on experimental assay constraints.

How do you approach Graph Theory in Bioinformatics - From Data to Discovery step by step?

The work is sequenced in 9 stages. It starts with Foundations of Graph Representation in Biological Systems, moves through Construction of Multi-Omics Biological Networks and Topological Analysis of Biological Networks, and ends at Integration of Graph Methods into Translational Workflows. Each stage carries its own topic list, so the sequence is followed rather than summarised.

What is in Module 1 of the Graph Theory in Bioinformatics - From Data to Discovery course?

Module 1 is Foundations of Graph Representation in Biological Systems. It works through select appropriate graph types (directed, undirected, weighted, bipartite) for modeling protein-protein interaction networks based on experimental assay constraints., map genomic coordinate data to interval graphs for detecting structural variants in cancer genomes using coverage depth profiles., implement vertex labeling schemes to encode functional annotations (e.g., GO terms) in gene.

How is the Graph Theory in Bioinformatics - From Data to Discovery course delivered?

The Graph Theory in Bioinformatics - From Data to Discovery course is fully self-paced with immediate online access after enrolment. Access does not expire and future updates are included at no cost. It can be taken on any device, and a certificate of completion is issued by The Art of Service when you finish.

How much does the Graph Theory in Bioinformatics - From Data to Discovery course cost?

The Graph Theory in Bioinformatics - From Data to Discovery course is $296 as a one time payment. There is no subscription, no per seat licence and no hidden fee. Enrolment carries a 30 day satisfied or refunded guarantee, so it can be assessed in full before you commit.

Closely related courses: Motif Discovery in Bioinformatics - From Data to Discovery, Mutation Analysis in Bioinformatics - From Data, Gene Fusion in Bioinformatics - From Data to Discovery, Quantitative Genetics in Bioinformatics - From Data.

More answers: what you get with every course, refund policy, all help answers.

This curriculum spans the technical and analytical rigor of a multi-phase bioinformatics initiative, comparable to developing an internal graph analytics platform for translational research, from foundational data modeling through production-grade validation and integration into clinical and regulatory workflows.

Module 1: Foundations of Graph Representation in Biological Systems

  • Select appropriate graph types (directed, undirected, weighted, bipartite) for modeling protein-protein interaction networks based on experimental assay constraints.
  • Map genomic coordinate data to interval graphs for detecting structural variants in cancer genomes using coverage depth profiles.
  • Implement vertex labeling schemes to encode functional annotations (e.g., GO terms) in gene regulatory networks while preserving semantic consistency.
  • Design edge semantics to distinguish between physical interactions, co-expression, and regulatory influences in multi-omics integration graphs.
  • Convert FASTA-derived sequence similarity outputs into adjacency matrices with e-value thresholds that balance sensitivity and spurious connections.
  • Integrate metadata (tissue type, disease state) into node attributes without introducing batch effects during downstream clustering.
  • Choose between adjacency list and matrix storage formats based on sparsity and query patterns in large-scale metabolic pathway graphs.
  • Validate topological assumptions (e.g., scale-free distribution) in constructed biological networks using statistical goodness-of-fit tests.

Module 2: Construction of Multi-Omics Biological Networks

  • Align transcriptomic, proteomic, and metabolomic datasets across different normalization schemes before integrating into a heterogeneous network.
  • Apply partial correlation methods to infer gene regulatory networks while correcting for latent confounders such as batch or cell cycle stage.
  • Construct tissue-specific interactomes by pruning generic PPI databases using expression thresholds from GTEx or Human Protein Atlas.
  • Weight edges in co-expression networks using mutual rank or biweight midcorrelation to reduce sensitivity to outliers.
  • Implement consensus network approaches across multiple cohorts to increase robustness of inferred interactions in pan-cancer studies.
  • Resolve identifier mismatches (Ensembl, Entrez, UniProt) during integration using stable cross-references from BridgeDB or UniProt mapping services.
  • Use time-series RNA-seq data to build dynamic graphs with temporal edges representing activation or repression events.
  • Balance edge density in integrated networks by applying FDR correction across multiple data types with differing noise profiles.

Module 3: Topological Analysis of Biological Networks

  • Compute node centrality measures (betweenness, closeness, eigenvector) on large interactomes using approximation algorithms to reduce computational load.
  • Identify bottleneck nodes in signaling pathways by combining topological position with knockout phenotype data from CRISPR screens.
  • Apply k-core decomposition to isolate densely connected modules associated with essential cellular functions.
  • Compare clustering coefficients across species to assess evolutionary conservation of network motifs in metabolic pathways.
  • Use shortest path analysis to infer potential indirect regulation between transcription factors and target genes.
  • Interpret hub node overrepresentation in disease-associated genes while controlling for gene length and connectivity bias.
  • Validate modular structure using modularity optimization algorithms (e.g., Louvain) with resolution parameters tuned to biological scale.
  • Assess network resilience by simulating targeted node removal (e.g., drug targets) and measuring fragmentation metrics.

Module 4: Graph Algorithms for Functional Inference

  • Implement label propagation to assign putative functions to uncharacterized proteins using known annotations in PPI networks.
  • Apply random walk with restart to prioritize candidate disease genes from seed genes in a genome-wide network.
  • Use shortest path trees to reconstruct signaling cascades from receptor to transcription factor in phosphoproteomics data.
  • Deploy maximum weight matching to pair paralogous genes with conserved interaction partners across species.
  • Optimize subgraph isomorphism queries to detect conserved regulatory motifs in promoter networks.
  • Apply minimum spanning tree algorithms to infer lineage relationships in single-cell differentiation trajectories.
  • Use graph coloring to assign non-overlapping functional labels in densely annotated pathways like KEGG or Reactome.
  • Implement belief propagation for probabilistic annotation transfer in noisy, incomplete interaction datasets.

Module 5: Scalable Graph Computing in Bioinformatics

  • Partition large-scale biological graphs (e.g., pan-genome graphs) using METIS or spectral methods to enable distributed processing.
  • Choose between in-memory (e.g., NetworkX) and out-of-core (e.g., GraphX) frameworks based on available RAM and query complexity.
  • Index graph elements using property graphs in Neo4j to accelerate queries for drug-target-pathway traversals.
  • Optimize graph serialization formats (GraphML, GEXF, Parquet) for efficient I/O during batch analysis of network ensembles.
  • Implement caching strategies for frequently accessed subgraphs (e.g., pathway neighborhoods) in interactive analysis tools.
  • Scale motif detection algorithms using MapReduce patterns across clusters of interaction networks from multiple studies.
  • Apply graph sketching techniques (e.g., HyperLogLog) to estimate connectivity statistics in streaming genomic data.
  • Monitor memory usage and garbage collection during long-running graph traversals in JVM-based systems.

Module 6: Network Alignment and Comparative Interactomics

  • Apply global network alignment algorithms (e.g., IsoRank) to identify conserved functional modules across species with divergent interactomes.
  • Weight node similarity by combining sequence homology with functional annotations to improve alignment accuracy.
  • Use local alignment tools (e.g., NETAL) to detect conserved pathway substructures in condition-specific networks.
  • Adjust alignment parameters to balance topological conservation with biological relevance in cross-species comparisons.
  • Validate aligned modules using independent functional evidence such as synthetic lethality or co-localization data.
  • Integrate tissue-specific networks into alignment frameworks to assess conservation of context-dependent interactions.
  • Address scalability issues in pairwise alignment of large networks by pre-filtering using domain architecture compatibility.
  • Interpret alignment scores in light of evolutionary distance and data completeness across species.

Module 7: Graph-Based Variant and Pathway Analysis

  • Map non-coding variants to regulatory networks by linking SNPs to target genes via chromatin interaction data (Hi-C, ChIA-PET).
  • Use shortest path enrichment to identify pathways connecting GWAS hits in complex trait studies.
  • Construct patient-specific mutational networks to identify co-occurring or mutually exclusive driver modules.
  • Apply diffusion algorithms (e.g., HotNet2) to detect significantly mutated subnetworks in cancer genomics.
  • Integrate CNV and expression data into weighted graphs to prioritize dysregulated pathways in tumor samples.
  • Validate pathway centrality findings using functional enrichment against gold-standard databases like MSigDB.
  • Adjust for background mutation rates when assessing subnetwork significance in somatic variant analysis.
  • Combine drug-target and disease networks to identify repurposing candidates via network proximity metrics.

Module 8: Uncertainty, Noise, and Validation in Biological Graphs

  • Model edge uncertainty using probabilistic graphs based on replicate agreement in high-throughput assays (e.g., Y2H, AP-MS).
  • Apply bootstrapping to assess confidence intervals for centrality measures in noisy interaction networks.
  • Filter spurious edges using negative datasets (e.g., Y2H decoys) and machine learning classifiers.
  • Quantify missing data bias by comparing network properties across datasets with varying coverage (e.g., tissue types).
  • Use cross-validation in supervised graph inference to prevent overfitting to known pathway annotations.
  • Integrate orthogonal evidence (e.g., co-expression, co-localization) to assign confidence scores to PPI edges.
  • Design control networks (e.g., degree-preserving randomizations) to assess statistical significance of observed topologies.
  • Document provenance and versioning of interaction databases to ensure reproducibility in network construction.

Module 9: Integration of Graph Methods into Translational Workflows

  • Embed network proximity metrics into clinical decision support systems for patient stratification.
  • Deploy graph-based biomarker panels in diagnostic pipelines with defined update cycles for network retraining.
  • Interface biological graphs with electronic health records using FHIR-compliant APIs for cohort identification.
  • Implement audit trails for network-derived hypotheses to meet regulatory requirements in drug development.
  • Balance interpretability and performance when using graph neural networks in preclinical target prediction.
  • Standardize graph exchange formats (e.g., BEL, SBGN) for sharing models across research and clinical teams.
  • Integrate network robustness analysis into safety assessment of therapeutic interventions.
  • Monitor drift in network-based models due to updates in reference databases or assay technologies.
!